BioSpace News Archive

The global blood-brain barrier market size is expected to reach USD 7.40 Billion in 2028 and register a steady CAGR during the forecast period, according to latest analysis by Emergen Research.

The global drug infusion systems market size reached USD 10.56 Billion in 2020 and is expected to register a CAGR of 7.1% during the forecast period, according to latest analysis by Emergen Research.

The global next generation implants market is expected to reach a market size of USD 4.45 Billion in 2028 and register a steady CAGR over the forecast period, according to latest analysis by Emergen Research.

The global tissue imaging market size is projected to be worth USD 27.32 Billion by 2027, according to a current analysis by Emergen Research.

Increasing prevalence of atrial fibrillation, advancements in AFib prediction and management, and improved precision in diagnosis of this condition are some key factors expected to drive market growth.

Revive Therapeutics Ltd. is pleased to announce that the Company has decided to expand research with Bucillamine, an oral drug shown to have promising anti-viral and anti-inflammatory capabilities and is being evaluated in a current Phase 3 clinical study for COVID-19, as a potential treatment for the Omicron variant (B.1.1.529).

cbdMD, Inc. (NYSE American: YCBD, YCBDpA) (the “Company”), one of the leading, and most highly trusted and recognized cannabidiol (CBD) brands, announced today that it has commenced a preclinical human study with researchers at the University of South Carolina.

Growing number of healthcare cyber-attacks and threats, rise in healthcare R&D, expansion of pharmaceutical industries, increasing healthcare manufacturers, and emphasis on health care digitalization are major factors expected to drive market growth.

Development of technologically advanced peptide synthesizers and availability of various peptide synthesis reagents are driving market revenue growth.

The Metastatic Breast Cancer (MBC) Heroes™ recognition program is designed to honor individuals who have inspired change, exemplified compassion, or made a significant impact in the lives of those affected by metastatic breast cancer.